ZLB BEHRING ANNOUNCES AVAILABILITY OF HUMATE-P WITH SMALLER DILUENT

ZLB Behring today announced that Humate-P (Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized) is now available featuring a smaller diluent — 50 percent less in all assay sizes. The new formulation, which bears the current safety and efficacy profile of Humate-P, offers added convenience to patients, healthcare professionals, and caregivers who administer Humate-P. Humate-P is the only factor concentrate approved by the U.S. Food & Drug Administration for use in treating adult and pediatric patients who experience spontaneous and trauma-induced bleeding episodes in severe von Willebrand Disease (VWD), and in mild or moderate VWD where the use of desmopressin is known or suspected to be inadequate.
PR Newswire